Healthy lifestyle choices — maintaining an active mind, a nutritious diet, and regular exercise — may help protect against cognitive…
Patricia Inacio, PhD
Patricia holds her PhD in cell biology from the University Nova de Lisboa, Portugal, and has served as an author on several research projects and fellowships, as well as major grant applications for European agencies. She also served as a PhD student research assistant in the Department of Microbiology & Immunology, Columbia University, New York, for which she was awarded a Luso-American Development Foundation (FLAD) fellowship.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Patricia Inacio, PhD
Inhibition of a protein called LIMK1 may help prevent the loss of dendritic spines — the connections between neurons in…
Women Carrying ApoE4 Gene More Susceptible Than Men to Toxic Tau Clumps in Brain, Study Suggests
Women who are carriers of the ApoE4 gene — a major genetic risk factor for the development of a late-onset…
Regardless of sex, people younger than age 65 who have a first-degree relative with Alzheimer’s disease generally showed poorer verbal…
A Phase 2a trial testing Oryzon’s investigational therapy vafidemstat for Alzheimer’s disease has enrolled its first patient in…
Vaccine Reduces Tau Tangle Formation, Improves Cognitive Functioning in Alzheimer’s Mouse Model
A vaccine produced using virus-like particles was able to improve cognitive functioning and reduce the accumulation of tau protein aggregates…
High Levels of ‘Bad’ Cholesterol Linked to Increased Risk of Early-onset Alzheimer’s, Study Suggests
High levels of “bad” cholesterol, known as low-density lipoprotein (LDL), might increase the risk of developing early-onset Alzheimer’s disease,…
Virtual reality may help improve the quality of life for people with dementia, including those with Alzheimer’s disease, by…
Tetra Discovery Partners is launching a Phase 2 clinical trial for BPN14770 — found to improve working memory in…
#AANAM – Memantine as Add-on Therapy Seen to Ease Psychosis, Other Advanced Alzheimer’s Symptoms
Adding memantine to a cholinesterase inhibitor can significantly ease certain neuropsychiatric symptoms, including psychosis and troubling motor or nighttime behavior,…